Add BrightSurf on Google Email

Science News Archive September 2014 - Page 4


Page 4 of 34

Dolphins are attracted to magnets

A study by French researchers has found that dolphins are able to discriminate between objects based on their magnetic properties, indicating a magenetic sense. The findings provide new evidence for magnetoreception in cetaceans and suggest they may use this ability to navigate themselves.

SourceSpringer·JournalZeitschrift für Didaktik der Naturwissenschaften·DateSep 29, 2014

New way to detox? 'Gold of Pleasure' oilseed boosts liver detoxification enzymes

Researchers found compounds in Camelina sativa seed that increase liver detoxification enzymes fivefold, showcasing its potential as a nutritional supplement and anti-cancer agent. The bioactive ingredients work synergistically when combined, similar to sulforaphane in broccoli.

Research suggests new strategies for killing TB bacterium

Scientists from Brown University and MIT have discovered new details on how ADEPs bind to the ClpP complex in Mtb, a crucial step towards optimizing these compounds for TB treatment. Novel ADEP analogs show improved binding and activation of ClpP, paving the way for designing new drugs.

SourceBrown University·JournalProceedings of the National Academy of Sciences·DateSep 29, 2014

Using the brain to forecast decisions

Researchers used neural recordings to predict when a rat would give up waiting for a delayed tone. The findings suggest that individual brain cells cast votes for actions, but the outcome is not predetermined.

SourceJLM&A, SA·JournalNature Neuroscience·DateSep 28, 2014

Smart, eco-friendly new battery to solve problems

Researchers at Uppsala University have developed a new battery concept using renewable biomaterials from alfalfa and pine resin, which can be recycled with low energy input and non-hazardous chemicals. The battery proved capable of delivering up to 99% of the energy output from a spent battery.

SourceUppsala University·JournalChemSusChem·DateSep 28, 2014

Adding cediranib to chemo improves progression-free survival for meta or recurrent cervical cancer

Adding cediranib to standard chemotherapy improves tumour shrinkage and adds a modest improvement in progression-free survival for patients with relapsed or metastatic cervical cancer. The study, published in Annals of Oncology, shows greater tumour shrinkage and increased median progression-free survival compared to chemotherapy alone.

SourceEuropean Society for Medical Oncology·JournalAnnals of Oncology·DateSep 28, 2014